Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Air Force Office of Small Business Program Support

Active
GSQ0516BM0037Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the Air Force Office of Small Business Program Support and is governed under the BPA Contract Number GS05Q15BMA0004, with the specific task order identified as GSQ0516BM0037 and task order ID ID05160011. This order, awarded to Spectrum Comm Inc., is a bridge task order facilitated by the General Services Administration (GSA) Federal Acquisition Service, specifically under Region 5 based in Chicago, IL. The contract falls under NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. A key modification to this contract (Modification 03) increased the ceiling value to $1.7 million, and it is notable that this contract was awarded as a Limited Sources Justification, meaning competition was restricted according to FAR regulations and endorsed by the GSA Competition Advocate. The contracting officer responsible for this order is Demetrius Smith, who can be contacted via phone or email for further information. The contract does not represent a request for quotes but rather serves as a posting to inform about the limited source procurement. The task order supports the Air Force’s small business office, emphasizing specialized program support within the federal acquisition framework. The administrative oversight from the GSA ensures compliance with federal acquisition requirements and the streamlined execution of services from the awarded vendor.

General Info

Spectrum Comm awarded $1.7M Air Force small business bridge task order via limited source procurement.

Agency

General Services Administration → GSA Fas Aas Region 5View Agency

NAICS

541711 - Research and Development in BiotechnologyView NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

(1)

Limited_Sources_Justification_ID05160011_-_Approved_2017-03-13.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyGeneral Services Administration → GSA Fas Aas Region 5
Contacts1 person available
OfficeCHICAGO, IL, 60604, USA
Organization / Agency
General Services Administration → GSA Fas Aas Region 5
View Agency Profile
Office AddressCHICAGO, IL, 60604, USA
Contacts
Demetrius SmithContracting Officer

Full Description

Show more
Order Number: GSQ0516BM0037 GSA Task Order Id: ID05160011 BPA Contract Number: GS05Q15BMA0004 Air Force Office of Small Business Program Support Modification 03 This posting is in accordance with FAR 8.405-6(a)(2)(i) Limiting Sources. THIS IS TO POST A Limited Sources Justification. THIS IS NOT A REQUEST FOR A QUOTE. The Limited Sources Justification changed the ceiling value to $1.7M. The bridge task order was awarded to Spectrum Comm Inc. under the GSA Air Force BPA GS05Q15BMA0004. The contracting activity is the General Services Administration, Federal Acquisition Service. The Limited Sources Justification was signed by the GSA Competition Advocate. Demetrius Smith Contracting Officer Email: demetrius.smith@gsa.gov

Similar Contracts

Same NAICS industry code

NAICS: 541711
New
Federal
Clinical Trial Design and Efficacy Data GenerationThe contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.
Aspr Administration For Strategic Preparedness And Response

POSTED

1 day ago

DEADLINE

in 30 days
View Details
NAICS: 541711
Grant
Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Collaborative Biomedical Research ExecutionThis contract enables a collaborative biomedical research effort focused on neurofibromatosis, requiring coordinated hypothesis-driven investigations led by an Initiating Principal Investigator and a Partnering Principal Investigator. The work encompasses the design of experiments, generation of empirical data, and rigorous milestone-based progress reporting to ensure scientific rigor and accountability. The project is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under the NAICS code for research and development in the physical, engineering, and life sciences, and is intended to advance understanding of neurofibromatosis through integrated scientific contributions. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is managed by the Department of Defense through its health research infrastructure. While no set-aside provisions or specific location details are provided, the emphasis is firmly on outcome-driven research with clearly defined deliverables tied to research milestones. The effort requires close alignment between the two principal investigators to ensure cohesive experimental planning, data integrity, and timely reporting, reflecting a strategic investment in translational medical science with potential implications for defense-relevant health conditions.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Collaborative Research Partnership (Partnering PI Option)This contract establishes a collaborative research partnership where a Partnering Principal Investigator from an external institution will co-lead the research effort alongside the primary team, sharing equal responsibility for scientific direction, project management, and deliverables. Funding is jointly allocated between the participating institutions, ensuring aligned resources and mutual accountability for outcomes, with the work focused on health-related research under the Defense Health Agency Contracting Activity. The initiative falls under NAICS code 541711, indicating it is within the scientific research and development sector, and is structured as a subcontract to support integrated, multi-institutional innovation. The opportunity was posted on June 18, 2026, with a deadline for responses set for September 28, 2026, providing potential partners a defined window to submit proposals. The partnership is expected to be conducted in alignment with the mission of the Department of Defense, addressing critical health priorities through joint scientific leadership. There is no set-aside designation specified, meaning eligibility is open to qualified institutions regardless of size or status, and no specific location is designated for performance, allowing flexibility in where the research activities are carried out as long as the objectives are met collaboratively.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in 2 months
View Details
NAICS: 541711
Grant
Kidney Cancer Clinical Research ExecutionThe contract titled Kidney Cancer Clinical Research Execution aims to advance clinical and translational research focused on kidney cancer through comprehensive scientific activities including study design, patient data collection, biomarker analysis, and therapeutic development. The work is intended to support the development of innovative treatments and diagnostic strategies by integrating clinical observations with laboratory research, ensuring findings are rapidly translated into improved patient outcomes. The project requires expertise in oncology research methodologies, rigorous data management, and interdisciplinary collaboration to address critical gaps in kidney cancer understanding and care. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541711, indicating it is related to research and development in the life sciences. The opportunity was posted on June 18, 2026, with a response deadline of September 28, 2026, providing potential applicants approximately three months to prepare and submit proposals. The place of performance and specific office address details are not specified, suggesting flexibility in location but requiring proposers to align with the overarching objectives of the Department of Defense’s medical research priorities. All work must demonstrate scientific excellence, feasibility, and direct relevance to advancing kidney cancer therapeutics within a clinical context.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in 2 months
View Details
NAICS: 541711
Federal
Infectious Disease Vaccine DevelopmentThe contract involves licensing the NanoFET platform to enable rapid-response vaccine development against viral and bacterial pathogens, leveraging its unique adjuvant-free immune activation and modular antigen integration capabilities. This technology allows for swift adaptation to emerging infectious threats by streamlining the design and production of vaccines without relying on traditional immune-stimulating additives, significantly reducing development timelines and enhancing safety profiles. The work is structured as a subcontract under the Department of Energy, with performance centered at Los Alamos, New Mexico, and is targeted toward advancing national defense and public health preparedness through next-generation vaccine platforms. The opportunity is open for proposals until December 18, 2026, and falls under NAICS code 541711, indicating it targets research and development in the physical, engineering, and life sciences. The contracting entity is Triad, the DOE Contractor, and the initiative aligns with broader federal efforts to build resilient, scalable biodefense capabilities. Participants must demonstrate technical proficiency in the NanoFET platform, experience in infectious disease vaccine design, and the capacity to execute rapid development cycles under strict timelines. Success in this effort will contribute directly to scalable, next-generation immunization technologies capable of addressing current and future biological threats.
Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

in 5 months
View Details

More opportunities from General Services Administration → GSA Fas Aas Region 5

Same awarding agency